Bimekizumab

ATC L04AC21 · 9 markets · 27 records

Bimekizumab 9 markets · 27 records Forms

AU 7 records · 4 strengths

  • 320 mg/2 mLinjectionBimzelx also in US·GB
  • 160 mg/1 mLinjectionBimzelx also in GB
  • 160 mg/mLinjectionBIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injectorBIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe unknown

Records without a stated strength · 1 Bimzelx

US 4 records · 2 strengths

GB 4 records · 2 strengths

CA 4 records · 2 strengths

ES 3 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 BIMZELX SOLUTION FOR INJECTION IN PRE-FILLED PEN 160MG/ML

    MX 1 records · 1 strengths

      Records without a stated strength · 1 Bimzelx

      TW 1 records · 1 strengths

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Bimzelx

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.